KHOP Studien UG (haftungsbeschraenkt)

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer1 trial
• Lung cancer1 trial

Phase

• Phase 32 trials

Status

• Not yet recruiting2 trials

Lead sponsor

• AIO-Studien-gGmbH1 trial
• Charite University, Berlin, Germany1 trial

Running trials

• Not yet recruiting

  Addition of Platinum-based Chemotherapy to Tislelizumab in PD-L1high Metastatic Non-small Cell Lung Cancer With a High Tumor Burden

  NCT07715396· Phase 3· AIO-Studien-gGmbH· Source

• Not yet recruiting

  Continuous or Intermittent Cetuximab Plus FOLFIRI as First-line Treatment in RAS/BRAF Wild-type mCRC Patients

  NCT07004413· Phase 3· Charite University, Berlin, Germany· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Lung cancer1 recruiting